ID

32598

Description

A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00813956

Link

https://clinicaltrials.gov/show/NCT00813956

Keywords

Versions (1)
  1. 11/8/18 11/8/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 8, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Triple Negative Breast Cancer NCT00813956

English

Eligibility Triple Negative Breast Cancer NCT00813956

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
invasive breast cancer
Description

Invasive carcinoma of breast

Data type

boolean

Alias
UMLS CUI [1]
C0853879
stage i-iiia disease
Description

Disease TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
er, pr, her2/neu-negative status
Description

Triple-Negative Breast Cancer Finding

Data type

boolean

Alias
UMLS CUI [1]
C2348819
no prior treatment for breast cancer
Description

Prior Therapy Absent Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0678222
age 18 years of greater
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
normal renal, liver function
Description

Renal function | Liver function

Data type

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0232741
normal hematologic status
Description

Hematologic function

Data type

boolean

Alias
UMLS CUI [1]
C0221130
ecog performance status 0, 1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
evaluation by a surgeon to determine breast conservation eligibility
Description

Eligibility Determination Breast-Conserving Surgery

Data type

boolean

Alias
UMLS CUI [1,1]
C0013893
UMLS CUI [1,2]
C0917927
women of childbearing potential must have a documented negative pregnancy test within 2 months of study trial entry and agree to birth control during the duration of the trial therapy
Description

Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
ability to understand and the willingness to sign a written informed consent document
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
metastatic breast cancer
Description

Secondary malignant neoplasm of female breast

Data type

boolean

Alias
UMLS CUI [1]
C0346993
inoperable breast cancer, including stage iiib and iiic
Description

Breast Carcinoma Inoperable TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0205187
UMLS CUI [1,3]
C3258246
tumor size less than 1 centimeter
Description

Tumor size

Data type

boolean

Alias
UMLS CUI [1]
C0475440
prior surgery, systemic therapy, or radiotherapy for the current cancer
Description

Operative Surgical Procedures Previous Malignant Neoplasm | Systemic therapy Malignant Neoplasm | Prior radiation therapy Malignant Neoplasm

Data type

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C0205156
UMLS CUI [1,3]
C0006826
UMLS CUI [2,1]
C1515119
UMLS CUI [2,2]
C0006826
UMLS CUI [3,1]
C0279134
UMLS CUI [3,2]
C0006826
hormone receptor-positive breast cancer
Description

Hormone receptor positive malignant neoplasm of breast

Data type

boolean

Alias
UMLS CUI [1]
C1562029
her2/neu-positive breast cancer
Description

HER2-positive carcinoma of breast

Data type

boolean

Alias
UMLS CUI [1]
C1960398
any concurrent condition which in the investigator's opinion makes it inappropriate for the patient to participate in the trial or which would jeopardize compliance with the protocol
Description

Condition Study Subject Participation Status Inappropriate | Condition compromises Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C1548788
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C2945640
UMLS CUI [2,3]
C0525058
pregnant or nursing women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
receipt of any investigational agents within 30 days prior to commencing study treatment
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
Back to the top of the page

Similar models

Eligibility Triple Negative Breast Cancer NCT00813956

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast
Item
invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Disease TNM clinical staging
Item
stage i-iiia disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Triple-Negative Breast Cancer Finding
Item
er, pr, her2/neu-negative status
boolean
C2348819 (UMLS CUI [1])
Prior Therapy Absent Breast Carcinoma
Item
no prior treatment for breast cancer
boolean
C1514463 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
Age
Item
age 18 years of greater
boolean
C0001779 (UMLS CUI [1])
Renal function | Liver function
Item
normal renal, liver function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
Hematologic function
Item
normal hematologic status
boolean
C0221130 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0, 1
boolean
C1520224 (UMLS CUI [1])
Eligibility Determination Breast-Conserving Surgery
Item
evaluation by a surgeon to determine breast conservation eligibility
boolean
C0013893 (UMLS CUI [1,1])
C0917927 (UMLS CUI [1,2])
Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods
Item
women of childbearing potential must have a documented negative pregnancy test within 2 months of study trial entry and agree to birth control during the duration of the trial therapy
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Informed Consent
Item
ability to understand and the willingness to sign a written informed consent document
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Secondary malignant neoplasm of female breast
Item
metastatic breast cancer
boolean
C0346993 (UMLS CUI [1])
Breast Carcinoma Inoperable TNM clinical staging
Item
inoperable breast cancer, including stage iiib and iiic
boolean
C0678222 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Tumor size
Item
tumor size less than 1 centimeter
boolean
C0475440 (UMLS CUI [1])
Operative Surgical Procedures Previous Malignant Neoplasm | Systemic therapy Malignant Neoplasm | Prior radiation therapy Malignant Neoplasm
Item
prior surgery, systemic therapy, or radiotherapy for the current cancer
boolean
C0543467 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
C1515119 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C0279134 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
Hormone receptor positive malignant neoplasm of breast
Item
hormone receptor-positive breast cancer
boolean
C1562029 (UMLS CUI [1])
HER2-positive carcinoma of breast
Item
her2/neu-positive breast cancer
boolean
C1960398 (UMLS CUI [1])
Condition Study Subject Participation Status Inappropriate | Condition compromises Protocol Compliance
Item
any concurrent condition which in the investigator's opinion makes it inappropriate for the patient to participate in the trial or which would jeopardize compliance with the protocol
boolean
C0348080 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C2945640 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Investigational New Drugs
Item
receipt of any investigational agents within 30 days prior to commencing study treatment
boolean
C0013230 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial